SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-110006"
 

Search: onr:"swepub:oai:DiVA.org:umu-110006" > Effect of Nateglini...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events

Holman, Rury R. (author)
Haffner, Steven M. (author)
McMurray, John J. (author)
show more...
Bethel, M. Angelyn (author)
Holzhauer, Bjoern (author)
Hua, Tsushung A. (author)
Belenkov, Yuri (author)
Boolell, Mitradev (author)
Buse, John B. (author)
Buckley, Brendan M. (author)
Chacra, Antonio R. (author)
Chiang, Fu-Tien (author)
Charbonnel, Bernard (author)
Chow, Chun-Chung (author)
Davies, Melanie J. (author)
Deedwania, Prakash (author)
Diem, Peter (author)
Einhorn, Daniel (author)
Fonseca, Vivian (author)
Fulcher, Gregory R. (author)
Gaciong, Zbigniew (author)
Gaztambide, Sonia (author)
Giles, Thomas (author)
Horton, Edward (author)
Ilkova, Hasan (author)
Jenssen, Trond (author)
Kahn, Steven E. (author)
Krum, Henry (author)
Laakso, Markku (author)
Leiter, Lawrence A. (author)
Levitt, Naomi S. (author)
Mareev, Viacheslav (author)
Martinez, Felipe (author)
Masson, Chantal (author)
Mazzone, Theodore (author)
Meaney, Eduardo (author)
Nesto, Richard (author)
Pan, Changyu (author)
Prager, Rudolf (author)
Raptis, Sotirios A. (author)
Rutten, Guy E. H. M. (author)
Sandström, Herbert (author)
Umeå universitet,Allmänmedicin
Schaper, Frank (author)
Scheen, Andre (author)
Schmitz, Ole (author)
Sinay, Isaac (author)
Soska, Vladimir (author)
Stender, Steen (author)
Tamas, Gyula (author)
Tognoni, Gianni (author)
Tuomilehto, Jaako (author)
Villamil, Alberto S. (author)
Vozar, Juraj (author)
Califf, Robert M. (author)
show less...
 (creator_code:org_t)
2010
2010
English.
In: New England Journal of Medicine. - 0028-4793 .- 1533-4406. ; 362:16, s. 1463-1476
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND The ability of short-acting insulin secretagogues to reduce the risk of diabetes or cardiovascular events in people with impaired glucose tolerance is unknown. METHODS In a double-blind, randomized clinical trial, we assigned 9306 participants with impaired glucose tolerance and either cardiovascular disease or cardiovascular risk factors to receive nateglinide (up to 60 mg three times daily) or placebo, in a 2-by-2 factorial design with valsartan or placebo, in addition to participation in a lifestyle modification program. We followed the participants for a median of 5.0 years for incident diabetes (and a median of 6.5 years for vital status). We evaluated the effect of nateglinide on the occurrence of three coprimary outcomes: the development of diabetes; a core cardiovascular outcome that was a composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure; and an extended cardiovascular outcome that was a composite of the individual components of the core composite cardiovascular outcome, hospitalization for unstable angina, or arterial revascularization. RESULTS After adjustment for multiple testing, nateglinide, as compared with placebo, did not significantly reduce the cumulative incidence of diabetes (36% and 34%, respectively; hazard ratio, 1.07; 95% confidence interval [CI], 1.00 to 1.15; P = 0.05), the core composite cardiovascular outcome (7.9% and 8.3%, respectively; hazard ratio, 0.94, 95% CI, 0.82 to 1.09; P = 0.43), or the extended composite cardiovascular outcome (14.2% and 15.2%, respectively; hazard ratio, 0.93, 95% CI, 0.83 to 1.03; P = 0.16). Nateglinide did, however, increase the risk of hypoglycemia. CONCLUSIONS Among persons with impaired glucose tolerance and established cardiovascular disease or cardiovascular risk factors, assignment to nateglinide for 5 years did not reduce the incidence of diabetes or the coprimary composite cardiovascular outcomes. (ClinicalTrials.gov number, NCT00097786.)

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Allmänmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- General Practice (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view